<DOC>
	<DOCNO>NCT00255489</DOCNO>
	<brief_summary>The purpose study characterize safety profile ZD1839 combination Palliative thoracic Radiotherapy patient non-small cell lung cancer</brief_summary>
	<brief_title>A Phase I Study ZD1839 Palliative Thoracic Radiotherapy Patients With Non-small-cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Provision write informed consent Patients require low dose palliative thoracic irradiation field size le equal 150cm2 Histologically cytologically conform nonsmall cell lung cancer Aged 18 Previous thoracic radiotherapy Any condition may predispose patient suffer individual drugrelaged DLT ( dose limit toxicity ) event Known hypersensitivity component study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>